AIFinancial Timesabout 2 hours ago
Insilico Medicine and CMS Expand CNS Collaboration
1 min read
Insilico Medicine and CMS announced additional collaborations in CNS diseases, deepening their partnership in AI-powered R&D acceleration. The companies are expanding work on central nervous system conditions using artificial intelligence for drug discovery and development.
Level
Hype check
Tap to vote and see what everyone thinks.
